Stuart A Thompson

US Patent:

6803231, Oct 12, 2004

Filed:

Sep 21, 1999

Appl. No.:

09/355793

Inventors:

Martin Blaser - Nashville TN
Joel Dworkin - Kirkwood MO
Stuart A. Thompson - Evans GA

Assignee:

Vanderbilt University - Nashville TN

International Classification:

A01N 6300

US Classification:

435325, 435348, 435362, 435365, 435367, 4352523, 43525233, 43525231, 4352542, 43525421, 4353201, 435 691, 536 237, 4241641

Abstract:

The present invention provides a mutant strain in which one or more sapA homologs are altered by an inserted DNA cassette so that the encoded S-layer proteins represent a chimera between the native S-layer proteins and a heterologous peptide encoded by the inserted cassette. Preferably, the heterologous peptide is an immunogen of a pathogen and the mutant strain can be used to immunize a host to develop mucosal and systemic immune responses to such immunogen.

US Patent:

20050106159, May 19, 2005

Filed:

Aug 12, 2004

Appl. No.:

10/916932

Inventors:

Stuart Thompson - Evans GA, US

International Classification:

A61K039/00
A61K048/00

US Classification:

424185100, 514044000

Abstract:

The field of this invention is the development of therapeutic agents having immunogenic efficacy against . The present invention is directed to a method of producing monoclonal antibodies that are highly specific for epitopes of outer membrane proteins; to specific monoclonal antibodies made by using the epitopes; and to uses thereof. The invention is drawn further to immunogens comprising certain outer membrane proteins or portions thereof from

US Patent:

20080131453, Jun 5, 2008

Filed:

Nov 15, 2007

Appl. No.:

11/940625

Inventors:

Stuart A. Thompson - Evans GA, US

Assignee:

MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE - Augusta GA

International Classification:

A61K 39/106
C12P 21/04
A01K 67/00

US Classification:

4241901, 435 703, 800 8

Abstract:

The field of this invention is the development of therapeutic agents having immunogenic efficacy against . The present invention is directed to a method of producing monoclonal antibodies that are highly specific for epitopes of outer membrane proteins; to specific monoclonal antibodies made by using the epitopes; and to uses thereof. The invention is drawn further to immunogens comprising certain outer membrane proteins or portions thereof from

US Patent:

20200349352, Nov 5, 2020

Filed:

Dec 23, 2019

Appl. No.:

16/725438

Inventors:

- Tysons Corner VA, US
Mark IRIS - Tysons Corner VA, US
Stuart THOMPSON - Tysons Corner VA, US
Bill DWYER - Tysons Corner VA, US
Bhaskar ATHMANATHAN - Tysons Corner VA, US

Assignee:

Cvent, Inc. - Tysons Corner VA

International Classification:

G06K 9/00
H04L 29/08

Abstract:

Systems, methods, and computer-readable storage media for quantifying augmented reality interaction. An exemplary system can be configured to capture, via a camera of a mobile computing device, a video feed, and extract, via a processor of the mobile computing device, an image from the video feed. The system can then determine, via the processor, that the image corresponds to a stored image in a plurality of stored images stored in an image database, resulting in a determination, and retrieve, via the processor and based on the determination, interactive content associated with the stored image. The system can then display, via a display of the mobile computing device, the interactive content as an augmented reality overlay.